J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
September 25, 2021 at 07:00 AM EDT
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations.
